You are here: Home >Archive for the ‘Blood Pressure’ Category

Effects of Beta Blockers on Albuminuria in Diabetes

Not all beta blockers have the same effect on cardiovascular risk factors in patients with diabetes. The Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial found that, in the presence of an angiotensin-converting enzyme (ACE) inhibitor or an angio-tensin-receptor blocker (ARB), the beta blocker carvedilol (e.g., Coreg medication, Glaxo-SmithKline) preserved glycemic control, [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

CIP-Fenofibrate for Cholesterol Disorders

Final approval has been granted for CIP-Fenofibrate (Lipofen, Cipher Pharmaceuticals), a novel formulation of the active ingredient fenofibrate, which is used in the treatment of hyperlipidemia.
Three dosages were approved: 50, 100 and 150 mg. The 150-mg strength is equivalent to Abbott’s Tricor 160 mg (under fed, not fasting, conditions). The new agent’s absorption is increased [...]

Tags:

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Generic Pravachol Available For Hyperlipidemia

The first generic version of Bristol-Myers Squibb’s Generic Pravachol (Pravastatin Sodium Tablets) has been approved.
Pravastatin medication is indicated for the treatment of patients with high cholesterol levels or who are at increased risk for atherosclerosis-related cardiac and cardiovascular events (e.g., heart attack and stroke). Bristol-Myers Squibb’s patent for the drug expired on April 20, 2006.
Pravastatin [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Reducing Warfarin Interactions

It’s not uncommon for patients who take warfarin generic to be taking other drugs— or for those drugs to have a significant potential for interaction.
Researchers from Kaiser Permanente and Northwest Permanente in Portland, Oregon, and from Harvard University in Boston evaluated the effectiveness of electronic medical record alerts. In one retrospective review, they found 65% [...]

Tags:

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Of Heart Attacks

Clopidogrel bisulfate (Plavix, Bristol-Myers Squibb/Sanofi-Aventis) has been approved for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI) and who are not scheduled for angioplasty (coronary artery repair).
A STEMI is a severe heart attack caused by the sudden, total blockage of an artery. The drug prevents subsequent blockage [...]

Tags:

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Ezetimibe/Simvastatin Label Revision

The product label for generic ezetimibe/ medication simvastatin (Vytorin drug, Merck/Schering-Plough) may now show that it was more effective than generic rosuvastatin calcium (Crestor, AstraZeneca) in lowering low-density lipoprotein-cholesterol levels at all doses that were compared. In a study of 2,959 patients, high cholesterol levels were reduced by 52% to 61% with Vytorin 10/20 to [...]

Tags: ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Generic Pravachol For Lowering Lipids

Barr Pharmaceuticals, Inc. and its subsidiary Pliva d.d. have announced that Pliva has received final approval from the FDA for its ANDA to manufacture and market Pravastatin tablets in dosages of 10 mg, 20 mg, and 40 mg. The tablets are the generic version of Bristol-Myers Squibb’s Pravachol tablets. Pliva has also received tentative ap­proval [...]

Tags:

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS
 Page 1 of 2  1  2 »